These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2555006)

  • 1. Foscarnet prophylaxis in marrow transplant recipients.
    Ringden O; Lonnqvist B; Aschan J; Sundberg B
    Bone Marrow Transplant; 1989 Nov; 4(6):713. PubMed ID: 2555006
    [No Abstract]   [Full Text] [Related]  

  • 2. Extrapulmonary cytomegalovirus disease in transplant patients.
    Petersen EA
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):13-6. PubMed ID: 1647557
    [No Abstract]   [Full Text] [Related]  

  • 3. Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation.
    Drobyski WR; Knox KK; Carrigan DR; Ash RC
    Transplantation; 1991 Jul; 52(1):155-7. PubMed ID: 1650043
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of cytomegalovirus pneumonia in transplant patients.
    Reed EC
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):8-12. PubMed ID: 1647562
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients.
    Reusser P; Gambertoglio JG; Lilleby K; Meyers JD
    J Infect Dis; 1992 Sep; 166(3):473-9. PubMed ID: 1323614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of cytomegalovirus to intravenous foscarnet treatment.
    Akesson-Johansson A; Lernestedt JO; Ringdén O; Lönnqvist B; Wahren B
    Bone Marrow Transplant; 1986 Dec; 1(2):215-20. PubMed ID: 2844334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of cytomegalovirus infections].
    Chiba S
    Nihon Rinsho; 1989 Feb; 47(2):440-5. PubMed ID: 2542666
    [No Abstract]   [Full Text] [Related]  

  • 8. Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.
    Ganly PS; Arthur C; Goldman JM; Schulenburg WE
    Postgrad Med J; 1988 May; 64(751):389-91. PubMed ID: 2849092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
    Gluckman E; McMazeron ; Keable H; Meletis J; Bombail D; Jolivet I; Huart JJ; Nebout T; Cavazzana M; De Castro H
    Nouv Rev Fr Hematol (1978); 1987; 29(1):17-21. PubMed ID: 3035485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the replication of herpes viruses by phosphonoacetate and related compounds.
    Newton AA
    Adv Ophthalmol; 1979; 38():267-75. PubMed ID: 230719
    [No Abstract]   [Full Text] [Related]  

  • 11. [Myelo-meningoradiculitis secondary to cytomegalovirus infection in a non immunocompromised patient. Treatment with foscarnet].
    Rogeaux O; Bedos JP; Wolf M; Vachon F
    Ann Med Interne (Paris); 1992; 143(3):219-20. PubMed ID: 1326248
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients.
    Ringdén O; Lönnqvist B; Paulin T; Ahlmén J; Klintmalm G; Wahren B; Lernestedt JO
    J Antimicrob Chemother; 1986 Mar; 17(3):373-87. PubMed ID: 3009383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients.
    Klintmalm G; Lönnqvist B; Oberg B; Gahrton G; Lernestedt JO; Lundgren G; Ringdén O; Robert KH; Wahren B; Groth CG
    Scand J Infect Dis; 1985; 17(2):157-63. PubMed ID: 2992074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients.
    Aschan J; Ringdén O; Ljungman P; Lönnqvist B; Ohlman S
    Scand J Infect Dis; 1992; 24(2):143-50. PubMed ID: 1322557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
    Ahlmén J; Wijnween AC; Brynger H; Lycke E
    Scand J Urol Nephrol Suppl; 1985; 92():41-4. PubMed ID: 3008316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytomegalovirus infection in patients after lung transplantation].
    Cerrina J; Le Roy Ladurie F
    Presse Med; 1992 Mar; 21(11):503-6. PubMed ID: 1315436
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation.
    Locke TJ; Odom NJ; Tapson JS; Freeman R; McGregor CG
    J Heart Transplant; 1987; 6(2):120-2. PubMed ID: 3040944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
    Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
    J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of cytomegalovirus infections in immunosuppressed patients].
    Michon C; Girard PM; Ngovan P; Simonpoli AM; Le Hoang P
    Ann Med Interne (Paris); 1988; 139(7):511-5. PubMed ID: 2854380
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of HTLV-III/LAV replication by foscarnet.
    Sarin PS; Taguchi Y; Sun D; Thornton A; Gallo RC; Oberg B
    Biochem Pharmacol; 1985 Nov; 34(22):4075-9. PubMed ID: 2415134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.